Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New coordinated care approach aims to boost stroke recovery

NCT ID NCT04000971

Disease control Sponsor: Vanderbilt University Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new way of caring for stroke patients that brings together doctors, nurses, and family members using technology and teamwork. About 1,200 adults who had a stroke took part. The goal was to see if this coordinated care helps people recover better and have a higher quality of life after leaving the hospital.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

1,196 people

The number who actually took part.

Started

Feb 2020

Finished

Sep 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18+. * Clinical diagnosis of acute stroke with brain imaging compatible with intracerebral hemorrhage or ischemic stroke (including normal brain scan); see International Classification of Disease 10 (ICD 10) codes. * English or Spanish speaking subjects. * Patient admitted within 7 days of their index stroke event. * Patient is discharged alive and not to hospice care. * Patient living at discharge within the geography of recruitment for that C3FIT site. * Pre-morbid Modified Rankin Score (mRS) score of 0-1. * Patient and/or surrogate give consent to participate after an informed consent process. * Patients who go to rehabilitation inpatient therapy or other care facilities are eligible, as long as they reside in the geographic are of recruitment and do not go to hospice care. Exclusion Criteria: * Clinical transient ischemic attack (TIA)38-41 is excluded even if there is a computerized tomography (CT) or magnetic resonance imaging (MRI) lesion corresponding to the clinical syndrome at presentation. * Already enrolled or planned enrollment in another clinical trial for which participation in C3FIT would be compromised with regard to follow-up assessment of outcomes or continuation in C3FIT. * Patients with a planned admission to hospice care prior to consent. * Patients not anticipated to survive for 1-year due to neurological or other medical status (i.e., advanced cancer, hospice care, heart disease, etc.). * Patients who in the opinion of the site investigator cannot be involved in follow up care. * Inability or unwillingness of subject or legal guardian/representative to understand and cooperate with study procedures or provide informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Engagement, patient are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Hemorrhagic Stroke intracerebral hemorrhage ischemic stroke Patient Participation stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Engagement, patient Stroke Stroke hemorrhagic Stroke sequelae Stroke, acute Stroke, ischemic

Contacts and locations

Locations

  • Augusta University Medical Center

    Augusta, Georgia, 30912, United States

  • Baptist Memorial Hospital

    Memphis, Tennessee, 38120, United States

  • Covenant Health Fort Sanders Regional Medical Center

    Knoxville, Tennessee, 37916, United States

  • Doctors Hospital Renaissance

    Edinburg, Texas, 78539, United States

  • Emory University/Grady Health

    Atlanta, Georgia, 30303, United States

  • Hartford Hospital

    Hartford, Connecticut, 06102, United States

  • Intermountain

    Las Vegas, Nevada, 89128, United States

  • Johnson City Medical Center at Ballad Health

    Johnson City, Tennessee, 37604, United States

  • Mayo Clinic

    Jacksonville, Florida, 32224, United States

  • Mayo Clinic Hospital

    Phoenix, Arizona, 85054, United States

  • Medical University of South Carolina

    Charleston, South Carolina, 29425, United States

  • Northwestern University

    Chicago, Illinois, 60611, United States

  • Ohio Health Riverside Methodist Hospital

    Columbus, Ohio, 43214, United States

  • Penn State

    State College, Pennsylvania, 16802, United States

  • University of Alabama at Birmingham

    Birmingham, Alabama, 35233, United States

  • University of Kansas Medical Center

    Kansas City, Kansas, 66160, United States

  • University of Louisville Hospital

    Louisville, Kentucky, 40202, United States

  • University of New Mexico Health Sciences Center

    Albuquerque, New Mexico, 87131, United States

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania, 15213, United States

  • University of Wisconsin Madison

    Madison, Wisconsin, 53705, United States

  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37322, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.